Predicting Lethal Outcome (Cause) And Understanding Key Biomarkers Linked With Acute Myocardial Infarction Using Deep Artificial Neural Network And Ensemble Of Machine Learning Methodologies

Abstract: Cardiovascular disease is still one of the main causes of death around the world. Acute myocardial infarction (MI), or heart attack, claims millions of lives each year. MI happens when blood flow to the coronary arteries is blocked or reduced, which causes permanent damage to the heart muscle. Without treatment, this can lead to cardiac arrest, where the heart stops pumping blood to the organs, resulting in organ failure and death. Even survivors often face serious problems like heart failure, pulmonary edema, and asystole. Research shows that 5 to 10 percent of survivors die within the first year after an MI, and nearly half need to be hospitalized again. Early thrombolytic treatment leads to better outcomes, so there is a clear need for faster and more accurate ways to diagnose MI. Right now, doctors usually review patient history and use their own experience to find the causes of MI. This process takes a lot of time and can be inconsistent. Detecting MI accurately and quickly can help patients take better care of themselves and prevent fatal events. In this study, we introduce an automated model to predict deadly outcomes of MI and help doctors understand important biomarkers linked to its complications. This approach aims to make diagnosis clearer, faster, and more affordable. The process includes preparing the data, filling in missing values, and handling imbalanced data using SVMSMOTE, ADASYN, and class-weighted methods. We use wrapper and embedded feature selection to find the most important variables, then scale the features for consistency. The model combines Logistic Regression, Random Forest, Light-GBM, and Bagging SVM, and is further improved with an artificial neural network to increase accuracy. We evaluate all models using precision, recall, and other key measures to find the best option for clinical use.

• The paper demonstrates an automated ensemble and deep neural pipeline for predicting lethal outcomes post-MI while identifying robust biomarker signatures.
• It employs advanced techniques including iterative imputation, feature engineering, and ADASYN oversampling to address class imbalance in a dataset of 1,700 patient records.
• The study achieves competitive performance between ANN and ensemble methods, emphasizing the critical role of domain-specific biomarker analysis for clinical decision support.

Predicting Lethal Outcome and Key Biomarkers in Acute Myocardial Infarction Using Deep Neural and Ensemble Methods

Introduction

The study "Predicting Lethal Outcome (Cause) And Understanding Key Biomarkers Linked With Acute Myocardial Infarction Using Deep Artificial Neural Network And Ensemble Of Machine Learning Methodologies" (2607.00472) investigates the development and evaluation of automated models for predicting lethal complications following acute myocardial infarction (AMI). The primary goal is twofold: to stratify causes of post-MI lethality using robust data-driven methods and to identify significant biomarkers influencing these outcomes.

This work responds to the clinical need for scalable, reproducible risk prediction systems capable of assisting decision-making in high-stakes, time-sensitive situations where physician assessments are often subjective, inconsistent, and prone to delays due to data complexity and class imbalance in real world datasets.

Methodology

The dataset, sourced from the UCI Mirkes "Myocardial Infarction Complications" repository, comprises 1,700 patient records with 113 variables incorporating demographic, clinical, and biochemical data, along with 12 distinct post-AMI complications as candidate outcomes for multiclass modeling. Rigorous data curation involved an iterative imputation protocol for missingness, stringent feature engineering, and selection using both wrapper (RFE) and embedded (Extra Trees, Elastic Net) strategies.

Class imbalance—a pervasive issue in medical datasets due to the preponderance of non-lethal or unknown outcomes—was explicitly controlled using SVM-SMOTE, ADASYN, and class-weighted methods, with ADASYN providing near-equal class representation in the training set. Following scaling and encoding, a reduced feature space of 70 variables was deployed for model training.

Classification models included baseline Logistic Regression (LR), Random Forest (RF), LightGBM, and a Bagging SVM. Additional stacked meta-learners aggregated the predictions of these base models. Significantly, the framework incorporated a deep artificial neural network (ANN), allowing performance benchmarking of classical ML against a deep learning paradigm.

Model evaluation strictly followed multiclass metrics (precision, recall, weighted F1, ROC-AUC) on a held-out test set, focusing on sensitivity to minority classes that represent clinically critical yet underrepresented complications.

Results

The work presents a systematic comparison of classifier performance before and after class balancing. Notably, all models demonstrated high accuracy (>0.85) for the dominant "unknown" class but struggled with rare outcomes such as pulmonary edema, myocardial rupture, and thromboembolism—a manifestation of class imbalance and inter-class overlap in the input feature space.

Strong empirical findings include:

• The best performing classical ensemble, Random Forest with class-weighted loss, achieved weighted F1 of 0.80 and ROC-AUC of 0.82, with superior sensitivity for intermediate prevalence outcomes when compared to baselines.
• The ANN classifier yielded comparable results (weighted F1 and AUC ~0.80), but required significantly more data and computational resources, with marginal gains over optimized ensemble models.
• Oversampling via ADASYN improved minority class sensitivity at the expense of some specificity in the majority class. Class-weighted techniques produced more stable generalization on out-of-distribution test samples.
• Key predictors consistently identified across modeling strategies included age, systolic and diastolic blood pressure at ICU admission (S_AD_ORIT, D_AD_ORIT), serum potassium (K_BLOOD), serum AlAT (ALT_BLOOD), presence of atrial fibrillation (ECG features), and use of certain medications/procedures within the first 72 hours of hospitalization (e.g., NSAID, heparin).

Discussion

The systematic pipeline outlined—comprising advanced imputation, outlier management, multi-tier feature selection, explicit imbalance handling, and comprehensive model comparison—offers a reproducible paradigm for similar risk stratification tasks in clinical informatics. The findings underscore the difficulty of achieving high recall for rare but catastrophic events post-AMI, even with state-of-the-art imbalance mitigation and flexible non-linear models.

The comparable performance of ANN and ensemble methods in this structured tabular context highlights the continued importance of domain-informed feature engineering and the need for larger, more granular datasets to fully capitalize on deep learning’s representational capacity.

The explicit identification of robust biomarkers via intersection of selection methods enhances model transparency and provides tangible variables for risk stratification, supporting translational application in clinical workflows. The persistence of age, blood pressure, serum potassium, and key ECG findings mirrors established cardiac literature, validating the approach while providing quantitative mapping between input variables and lethal endpoints.

Implications and Future Directions

Practically, this research supports integration of automated risk scoring tools into EMR systems, aiding early triage and targeted intervention for high-risk post-MI patients. It also frames an extensible methodology for addressing multiclass outcome stratification in other high-dimensional, imbalanced medical datasets.

Theoretically, the study demonstrates the limitations of existing ML/DL models in capturing nuanced, low-prevalence complications, underscoring the continued need for advanced imbalance learning techniques, robust uncertainty quantification, and systematic external validation on geographically distinct cohorts. Ensembling remains a robust baseline, and further exploration of hybrid architectures (e.g., attention models, graph neural networks on longitudinal/time-series EHR data) may offer incremental gains.

Future work should address:

• Refinement of model calibration for clinical interpretability
• Incorporation of longitudinal and imaging modalities (e.g., serial ECG or echo) into multimodal learning pipelines
• Federated learning strategies to aggregate across international datasets while preserving patient privacy
• Continuous monitoring and updating of model weights as new outcome data become available, supporting adaptive risk prediction in dynamic clinical environments

Conclusion

This study establishes a reproducible, technically rigorous pipeline for multiclass risk prediction in acute MI, balancing methodological complexity with clinical interpretability. While ensemble and neural methods deliver similar discriminative capacity when paired with modern imbalance techniques, their true value lies in augmenting—not replacing—domain-expert decision-making. The detailed biomarker analysis supports actionable clinical insight, while the modeling findings delineate current technical boundaries and critical avenues for future translational AI research in cardiology.

Reference:

"Predicting Lethal Outcome (Cause) And Understanding Key Biomarkers Linked With Acute Myocardial Infarction Using Deep Artificial Neural Network And Ensemble Of Machine Learning Methodologies" (2607.00472)